Valeos Pharma A/S — Credit Rating and Financial Key Figures
CVR number: 39696614
Østervej 2, 4960 Holeby
tel: 20651018
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | -1 277.00 | -3 377.00 | -5 901.90 | -5 838.51 | -3 846.79 |
| Employee benefit expenses | - 702.00 | -4 015.00 | -9 038.53 | -9 038.53 | -10 558.63 |
| Total depreciation | -20.00 | -2 354.40 | -2 354.40 | -3 113.59 | |
| EBIT | -1 979.00 | -7 412.00 | -17 294.83 | -17 231.43 | -17 519.01 |
| Other financial expenses | - 194.00 | - 797.00 | -3 873.17 | -3 936.56 | -4 181.99 |
| Pre-tax profit | -2 173.00 | -8 209.00 | -21 168.00 | -21 168.00 | -21 701.00 |
| Income taxes | 468.00 | 1 801.00 | 4 634.01 | 4 634.01 | 4 756.29 |
| Net earnings | -1 705.00 | -6 408.00 | -16 533.98 | -16 533.98 | -16 944.71 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Buildings | 1.00 | 49 200.10 | 49 200.10 | 46 215.08 | |
| Machinery and equipment | 17.00 | 161.00 | 259.07 | 259.07 | 176.21 |
| Advance payments and construction in progress | 19 240.00 | 40 307.00 | |||
| Tangible assets total | 19 257.00 | 40 469.00 | 49 459.16 | 49 459.16 | 46 391.29 |
| Investments total | 431.41 | 433.58 | |||
| Non-current other receivables | 332.00 | 333.00 | 431.41 | ||
| Long term receivables total | 332.00 | 333.00 | 431.41 | ||
| Semifinished products | 463.34 | 463.34 | 1 152.95 | ||
| Raw materials and consumables | 112.15 | ||||
| Finished products/goods | 1 021.50 | 1 021.50 | 1 457.84 | ||
| Inventories total | 1 484.84 | 1 484.84 | 2 722.95 | ||
| Current trade debtors | 248.56 | ||||
| Prepayments and accrued income | 160.00 | 451.95 | 451.95 | 755.53 | |
| Current other receivables | 2 050.00 | 1 815.00 | 1 866.20 | 1 866.20 | 1 382.49 |
| Current deferred tax assets | 539.00 | 1 807.00 | 7 401.54 | 7 401.54 | 6 209.25 |
| Short term receivables total | 2 589.00 | 3 782.00 | 9 719.69 | 9 719.69 | 8 595.83 |
| Cash and bank deposits | 68.00 | 5 359.00 | |||
| Cash and cash equivalents | 68.00 | 5 359.00 | |||
| Balance sheet total (assets) | 22 246.00 | 49 943.00 | 61 095.10 | 61 095.10 | 58 143.64 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 400.00 | 515.00 | 526.69 | 526.69 | 802.63 |
| Share premium account | 140.00 | 140.00 | 140.00 | 140.00 | 140.00 |
| Retained earnings | - 251.00 | 22 285.00 | 7 439.25 | 7 439.25 | 22 802.27 |
| Profit of the financial year | -1 705.00 | -6 408.00 | -16 533.98 | -16 533.98 | -16 944.71 |
| Shareholders equity total | -1 416.00 | 16 532.00 | -8 428.04 | -8 428.04 | 6 800.20 |
| Provisions | 6.00 | 1 153.72 | |||
| Capital loans | 21 087.00 | 22 729.00 | 26 566.64 | 26 566.64 | 24 980.85 |
| Non-current loans from credit institutions | 1 000.00 | 8 232.00 | 16 366.57 | 19 786.59 | 1 897.02 |
| Non-current other liabilities | 147.00 | 147.00 | 3 576.97 | 156.95 | 2 793.61 |
| Non-current liabilities total | 22 234.00 | 31 108.00 | 46 510.19 | 46 510.19 | 29 671.48 |
| Current loans from credit institutions | 17 650.58 | 17 650.58 | 18 771.64 | ||
| Current trade creditors | 778.00 | 1 583.00 | 4 529.71 | 4 529.70 | 1 093.58 |
| Current owed to participating | 204.00 | 208.00 | 216.49 | 216.49 | 220.82 |
| Other non-interest bearing current liabilities | 446.00 | 506.00 | 616.18 | 616.19 | 432.21 |
| Current liabilities total | 1 428.00 | 2 297.00 | 23 012.95 | 23 012.95 | 20 518.24 |
| Balance sheet total (liabilities) | 22 246.00 | 49 943.00 | 61 095.10 | 61 095.10 | 58 143.64 |
CreditReports API
- Company information
- Financial data
- Credit risk data
- All 400,000+ Danish companies
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.